Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

M. C. Müller, N. Gattermann, T. Lahaye, M. W.N. Deininger, A. Berndt, S. Fruehauf, A. Neubauer, T. Fischer, D. K. Hossfeld, F. Schneller, S. W. Krause, C. Nerl, H. G. Sayer, O. G. Ottmann, C. Waller, W. Aulitzky, P. le Coutre, M. Freund, K. Merx, P. PaschkaH. König, S. Kreil, U. Berger, H. Gschaidmeier, R. Hehlmann, Andreas Hochhaus

Research output: Contribution to journalArticle

105 Scopus citations

Fingerprint Dive into the research topics of 'Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C'. Together they form a unique fingerprint.

Medicine & Life Sciences